![](https://cdn.benzinga.com/files/images/story/2024/07/25/Enveric-drug-for-mental-health-disorders.jpeg?width=1200&height=800&fit=crop)
Non-Hallucinogenic Psychedelic Treatment For Mental Health Disorders Shows Potential To Be Dosed Orally
Psychedelics biotech Enveric Biosciences ENVB announced positive preclinical results of its EB-003 drug candidate to be delivered via oral administration. EB-003 is a new, neuroplastogenic molecule designed to treat serious mental health disorders without …